Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

Epidermal growth factor receptor (EGFR) mutations are common in non-small cell lung cancers, but rare in small cell lung cancers (SCLCs). In previous reports, some SCLC patients with EGFR mutations could benefit from EGFR tyrosine kinase inhibitors (TKIs). In this study, we reported a case in which...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Wang, Lingfei, Dong, Fangyuan, Su, Jie, Du, Guanjun, Shao, Yang, Liu, Ying, He, Xuequn, Bao, Liubin, Wang, Wei, Guo, Xin, Wang, Xi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379871/
https://ncbi.nlm.nih.gov/pubmed/32766137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados